Skip to main content

Advertisement

Log in

Hormone therapy in systemic lupus erythematosus

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Manzi SM, Stark VE, Ramsey-Goldman R: Epidemiology and classification of systemic lupus erythematosus. In Rheumatology edn 3. Edited by Hochberg M, Silman A, Smolen J, et al. Edinburgh. Elsevier; 2003: 1291–1296.

    Google Scholar 

  2. Buyon JP, Petri MA, Kim MY, et al.: The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Int Med 2005, 142:953–962.

    PubMed  CAS  Google Scholar 

  3. Writing Group for the Women’s Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002, 288:321–333.

    Article  Google Scholar 

  4. Speroff L: Clinical appraisal of the women’s health initiative. J Obstet Gynaecol Res 2005, 31:80–93.

    Article  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Domsic, R.T., Manzi, S. Hormone therapy in systemic lupus erythematosus. Curr Rheumatol Rep 7, 455–456 (2005). https://doi.org/10.1007/s11926-005-0051-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-005-0051-6

Keywords

Navigation